Denials Management
AI-Powered Performance. Gold Medal Results.
You need AI to stay competitive in revenue cycle—but managing it shouldn’t slow you down. AI technology requires elite expertise to implement, constant updates to maintain peak performance, and specialized knowledge to optimize results.
Aspirion delivers gold-medal AI without the complexity. No new systems to learn. No workflows to manage. Just superior financial outcomes.
Partnership Powered by Excellence
Improved Win Rate
64%
Clinical denials resolution rate
Faster Appeals
2.2x
Quicker from placement to first appeal with AI
Speed to closure
1.4x
Faster from placement to closure with AI
Real Results, Real AI
We manage the AI so you don’t have to. No new systems to learn, no additional workflows to manage—simply better financial outcomes for your organization. Each phase of our process leverages AI to extract the right information at the right time to generate accurate appeal letter drafts for human review.
Ingest & Analyze
Our proprietary AI-powered platform ingests and analyzes your denial letters and medical records using large language models (LLMs).
Compare
Our AI compares your documentation against trusted industry standards—including clinical care and medical coding guidelines plus payer policies.
Craft & Review
Appeal & Recover
The appeal is submitted according to precise payer guidelines, with results outperforming traditional human-written appeals with higher recoveries.
Our AI Delivers Real Results
Our proprietary AI revolutionizes denials management by analyzing complex medical documentation and payer contracts to craft compelling, evidence-based appeals.
With clinical and legal validation, our AI-generated appeals have delivered game-changing results in under a year—achieving a 64% resolution rate while cutting days to first appeal by 39% and overall closure time by 24%. This is just the beginning of AI’s transformative impact on revenue cycle management.
I love Aspirion. They are great. I think the AI-generated appeal letters for DRG downcoding that Aspirion is doing are based on some really good technology and content, and there is more to come. Aspirion obviously acquired Boost. Liana is just super impressed, and Aspirion is really starting to have an underpayment piece as well. So they are at a high level.
Contact Us
Aspirion is proud to be named back-to-back Best in KLAS for Denials Management Services in 2024 & 2025.
Contact us to find out how our highly-skilled denials team harnesses AI to meet your denials challenges head-on.
